Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Audentes Therapeutics, Inc. | 1,760,743 | reported | 25 Jul 2016 | tx 14+1,806,832−1,771,832 |
| Ophthotech Corp. | 1,714,111 | reported | 19 Jun 2020 | tx 4+34,282−3,484,100 |
| Inari Medical, Inc. | 17,040 | reported | 17 Nov 2020 | tx 4+164,825−3,188,165 |
| Oyster Point Pharma, Inc. | 3,726 | reported | 21 Dec 2021 | tx 4+51,556−253,030 |
| Clovis Oncology, Inc. | 0 | reported | 16 Nov 2011 | tx 10+2,172,889 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 Dec 2021 | OTHER | Oyster Point Pharma, Inc. | 200,213 | 0.00 USD | |
| 21 Dec 2021 | OTHER | Oyster Point Pharma, Inc. | 51,556 | 0.00 USD | |
| 21 Dec 2021 | OTHER | Oyster Point Pharma, Inc. | 1,261 | 0.00 USD | |
| 21 Dec 2021 | OTHER | Oyster Point Pharma, Inc. | 51,556 | 0.00 USD | |
| 17 Nov 2020 | OTHER | Inari Medical, Inc. | 18,925 | 0.00 USD | |
| 17 Nov 2020 | OTHER | Inari Medical, Inc. | 164,825 | 0.00 USD | |
| 17 Nov 2020 | OTHER | Inari Medical, Inc. | 3,004,415 | 0.00 USD | |
| 17 Nov 2020 | OTHER | Inari Medical, Inc. | 164,825 | 0.00 USD | |
| 19 Jun 2020 | OTHER | Ophthotech Corp. | 21,597 | 0.00 USD | |
| 19 Jun 2020 | OTHER | Ophthotech Corp. | 34,282 | 0.00 USD | |
| 19 Jun 2020 | OTHER | Ophthotech Corp. | 34,282 | 0.00 USD | |
| 19 Jun 2020 | OTHER | Ophthotech Corp. | 3,428,221 | 0.00 USD | |
| 25 Jul 2016 | CONVERSION | Audentes Therapeutics, Inc. | 198,410 | — | |
| 25 Jul 2016 | PURCHASE | Audentes Therapeutics, Inc. | 219 | 15.00 USD | first after silence |
| 25 Jul 2016 | PURCHASE | Audentes Therapeutics, Inc. | 34,781 | 15.00 USD | |
| 25 Jul 2016 | CONVERSION | Audentes Therapeutics, Inc. | 1,249 | — | |
| 25 Jul 2016 | CONVERSION | Audentes Therapeutics, Inc. | 3,029 | — | |
| 25 Jul 2016 | CONVERSION | Audentes Therapeutics, Inc. | 6,811 | — | |
| 25 Jul 2016 | CONVERSION | Audentes Therapeutics, Inc. | 1,081,477 | — | |
| 25 Jul 2016 | CONVERSION | Audentes Therapeutics, Inc. | 480,856 | — | |
| 25 Jul 2016 | CONVERSION | Audentes Therapeutics, Inc. | 6,811 | — | deriv |
| 25 Jul 2016 | CONVERSION | Audentes Therapeutics, Inc. | 198,410 | — | deriv |
| 25 Jul 2016 | CONVERSION | Audentes Therapeutics, Inc. | 480,856 | — | deriv |
| 25 Jul 2016 | CONVERSION | Audentes Therapeutics, Inc. | 1,081,477 | — | deriv |
| 25 Jul 2016 | CONVERSION | Audentes Therapeutics, Inc. | 1,249 | — | deriv |
1 purchase reported after at least 12 months of silence — most recent on 25 Jul 2016.